HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study-Reference-Cited by-同舟云学术

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

Published:2022-01 Issue:1 Volume:23 Page:172-184
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Naranbhai Vivek,Viard Mathias,Dean Michael,Groha Stefan,Braun David A,Labaki Chris,Shukla Sachet A,Yuki Yuko,Shah Parantu,Chin Kevin,Wind-Rotolo Megan,Mu Xinmeng Jasmine,Robbins Paul B,Gusev Alexander,Choueiri Toni K,Gulley James L,Carrington Mary

Funder

National Institutes of Health

US Department of Defense

Pfizer Ltd

Merck KGaA

Frederick National Laboratory for Cancer Research

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Genomic correlates of response to immune checkpoint blockade;Keenan;Nat Medicine,2019

2. Dissecting the immunogenomic biology of cancer for biomarker development;Van Allen;Nat Rev Clin Oncol,2021

3. Tumor mutational burden, toxicity, and response of immune checkpoint inhibitors targeting PD(L)1, CTLA-4, and combination: a meta-regression analysis;Osipov;Clin Cancer Res,2020

4. Comparison of biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade: a systematic review and meta-analysis;Lu;JAMA Oncol,2019

5. Patient HLA class I genotype influences response to immune checkpoint blockade therapy;Chowell;Science,2017

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies for the treatment of colorectal cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with Chemotherapy;Cancers;2024-09-07

3. HLA polymorphism impacts immune response to neoepitopes and survival in APOBEC-mutated cancers;2024-08-08

4. Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma;Current Medicinal Chemistry;2024-08

5. Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans;2024-07-16